Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

被引:100
作者
Queenan, AM [1 ]
Foleno, B [1 ]
Gownley, C [1 ]
Wira, E [1 ]
Bush, K [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA
关键词
D O I
10.1128/JCM.42.1.269-275.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Escherichia coli and Klebsiella pneumoniae isolates with extended-spectrum beta-lactamases (ESBLs) or AmpC cephalosporinases generally respond as predicted to NCCLS tests for ESBL production. However, inoculum size may affect MICs. The effect of inoculum level in clinical isolates expressing beta-lactamases were studied at inocula within 0.5 log unit of the standard inoculum, using broth microdilution methodology with ceftazidime, cefotaxime, cefepime, cefpodoxime, and aztreonam. Strains with TEM-1 or no beta-lactamases gave consistent MIC results with inocula of 10(5) and 10(6) CFU/ml. When the bacteria were screened for ESBL production and the lower inoculum was used, several strains with ESBLs, including CTX-M-10, TEM-3, TEM-10, TEM-12, TEM-6, SHV-18, and K1, gave false-negative results for one or more antimicrobial agents (MICs below the NCCLS screening concentration for detecting suspected ESBLs). When the higher inoculum was used, MICs of at least one antimicrobial agent increased at least fourfold in strains producing TEM-3, TEM-10, TEM-28, TEM-43, SHV-5, SHV-18, and K1. All antimicrobial agents showed an inoculum effect with at least one ESBL producer. Confirmatory clavulanate effects were seen for both inocula for all ESBL-producing strains with all antimicrobial agents tested, except for the CTX-M-10-producing E. coli with ceftazidime and the SHV-18-producing K. pneumoniae with cefotaxime. In kinetic studies, cefpodoxime and cefepime were hydrolyzed by ESBLs in a manner similar to that of cefotaxime. When total beta-lactamase activity and hydrolysis parameters were evaluated, however, no single factor was predictive of inoculum effects. These results indicate that the NCCLS screening and confirmation tests are generally predictive of ESBL production, but false-negative results can arise when a lower inoculum is used in testing.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 34 条
[1]   Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum β-lactamases [J].
Bedenic, B ;
Beader, N ;
Zagar, Z .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (11) :626-635
[2]   MULTIPLY RESISTANT KLEBSIELLA-PNEUMONIAE STRAINS FROM 2 CHICAGO HOSPITALS - IDENTIFICATION OF THE EXTENDED-SPECTRUM TEM-12 AND TEM-10 CEFTAZIDIME-HYDROLYZING BETA-LACTAMASES IN A SINGLE ISOLATE [J].
BRADFORD, PA ;
CHERUBIN, CE ;
IDEMYOR, V ;
RASMUSSEN, BA ;
BUSH, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :761-766
[3]   TEM-28 from an Escherichia coli clinical isolate is a member of the his-164 family of TEM-1 extended-spectrum beta-lactamases [J].
Bradford, PA ;
Jacobus, NV ;
Bhachech, N ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :260-262
[4]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[5]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[6]   An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae:: the importance of using cefpodoxime to detect extended-spectrum β-lactamases [J].
Brenwald, NP ;
Jevons, G ;
Andrews, JM ;
Xiong, JH ;
Hawkey, PM ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :195-U24
[8]   EFFECTIVE COOLING ALLOWS SONICATION TO BE USED FOR LIBERATION OF BETA-LACTAMASES FROM GRAM-NEGATIVE BACTERIA [J].
BUSH, K ;
SINGER, SB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (01) :82-84
[9]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[10]  
Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610